Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) is a publicly traded Healthcare sector company. As of July 5, 2026, TEVA trades at $34.64 with a market cap of $40.34B and a P/E ratio of 25.29. TEVA moved +3.32% today. Year to date, TEVA is +10.53%; over the trailing twelve months it is +103.17%. Its 52-week range spans $12.47 to $37.35. Analyst consensus is strong buy with an average price target of $42.38. Rallies surfaces TEVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for TEVA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $34.64 |
| Market Cap | $40.34B |
| P/E Ratio | 25.29 |
| EPS | $1.37 |
| Dividend Yield | 0.09% |
| 52-Week High | $37.35 |
| 52-Week Low | $12.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $14.14B |
| Net Income | $1.57B |
| Gross Margin | 63.90% |
9 analysts cover TEVA: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.38.